Mar 11, 2025
The Impact of Global Regulations on the Active Pharmaceutical Ingredient Industry
Mar 3, 2025
The Importance of Supply Chain Management and Dr. Reddy’s Excellence
Feb 10, 2025
Current Landscape of Cancer Treatment in India and Dr. Reddy's Role in Enhancing Care
Apr 2, 2025
Harnessing India's New Drug Development Capabilities for Global Impact
Jan 12, 2025
Global Development Strategy for Generic Formulations and APIs
Jan 6, 2025
APIs for Emerging Markets: Opportunities and Challenges
Dec 15, 2024
Formulation Strategies and Pharmaceutical Analysis for Anti-diabetic APIs
Dec 2, 2024
API Quality Control Technologies & Strategies: Current Advancements for Benefiting Pharma Companies
Oct 9, 2024
A year of growth & Sustainability
Aug 30, 2024
Understanding Nitrosamines and GTI Issues in APIs: A Comprehensive Overview with Dr. Reddy's Perspective
Aug 28, 2024
Innovative Approaches to API Production in 2024: Shaping the Future of Pharma Companies
Jul 30, 2024
Continuous Manufacturing Process and Its Impact on Pharma Manufacturing
Jul 25, 2025
Development of Niche Products at Dr. Reddys API
Jun 28, 2024
A Comparative Study on Naproxen Formulations
Jun 18, 2024
An effective strategy for the development of docetaxel
May 22, 2024
Preformulation Studies for Generic Omeprazole
May 15, 2024
A comparative study on enzalutamide Formulations
Apr 30, 2024
Navigating the Heart of Pharmaceuticals: An In-Depth Exploration of Active Pharmaceutical Ingredient Manufacturing for Essential Medicines
Apr 1, 2024
Presence of Organic Impurities in active pharmaceutical ingredients: An Overview
Mar 30, 2024
Strategies and Technologies for Enhancing Cost-Effectiveness in Active Pharmaceutical Ingredient (API) Production
Mar 29, 2024
Effective Formulation Development Strategies for Poorly Soluble Active Pharmaceutical Ingredients (APIs)
Feb 29, 2024
Ensuring Drug Safety: Comprehensive Analysis of Active Pharmaceutical Ingredient Lists
Feb 28, 2024
Unravelling the Science: Pharmaceutical Compositions and Process of Levetiracetam API
Nov 16, 2023
Impact of Venetoclax Exposure on Clinical Efficacy and Safety in Patients with Refractory Chronic Lymphocytic Leukemia
Aug 10, 2023
Demonstrating Equivalence of Generic Glatiramer Acetate: Ensuring Quality and Safety
May 25, 2023
Streamlining the Process: Preparing a Pharmaceutical Composition of Fosaprepitant API
Dec 30, 2022
Steps taken by Dr. Reddy's Laboratories in controlling the environmental risks and safety management in the manufacturing of APIs
Dec 7, 2022
Meeting the New Regulatory Requirements and Controlling of Nitrosamine Impurities in Sartan API Production
Sep 14, 2022
Effective Formulation Development Strategies for Poorly Soluble Active Pharmaceutical Ingredients
Sep 13, 2022
Reshaping the Pharmaceutical API Industry with Digital Transformation
Aug 2, 2022
7 Ways how Active Pharmaceutical Ingredients (APIs) Enable Indian Pharmaceutical Companies to Grow
Aug 2, 2022
How is the Indian Pharmaceutical industry gearing up for 2022-2023?
Apr 14, 2022
Impact of COVID-19 on Indian HPAPI industry
Apr 14, 2022
The synthesis of active pharmaceutical ingredients (APIs) using continuous flow chemistry
Sep 14, 2021
ANVISA Certification of GMP Pharmaceutical Ingredients for 61 of Dr Reddy’s APIs
Jul 7, 2021
Managing the Product Life Cycle: Naproxen API and formulations
May 27, 2021
Understanding Active Pharmaceutical Ingredients: CPHI talk by Dr. Ramani Susarla
Mar 31, 2021
EMA Nitrosamine Guidance – Deadline March 31, 2021
Nov 26, 2020
Patient centricity and supply chain security in 2021 - Rajesh Sadanandan speaks on CPhI Pharma Trends 2021
Nov 19, 2020
Dr. Reddy's research publication on simultaneous automated image analysis and Raman spectroscopy of powders at an individual particle level
Sep 14, 2020
A Paradigm Shift that Is Here to Stay - Sauri Gudlavalleti speaks to CME Manager on COVID-19 response
Sep 7, 2020
A Year of Challenge and Opportunity - Deepak Sapra, Global Head of PSAI speaks to The Medicine Maker
Sep 2, 2020
COVID-19 and What’s Next for API Sourcing?
Aug 25, 2020
Indian healthcare reform offers thriving pharmaceutical market opportunities: Interview with Deepak Sapra
Jun 1, 2020
Dr. Reddy’s is improving supply chain performance for Pregabalin API through large manufacturing capacity and backward integration
Dec 1, 2019
Enhancing Supply Chain Security for Levetiracetam API
免責事項
このウェブサイト上のいかなる情報も、製品またはサービスへの言及を含め、販売の申し出を構成するものではなく、販売の申し出を表すものと解釈されるものでもありません。有効な特許により保護されている製品は、商用目的で提供または提供されるものではありません。ただし、特定のケースでは、Dr. Reddy の独自の裁量により、現地の法的要件に従って、そのような製品の研究用数量が、規制免除が存在する場所に、インド特許法第 107A 条 (Bolar 免除) に基づく規制提出の目的で提供される場合があります。購入者は、それぞれの市場における特許シナリオを含む製品またはサービスについて独自の評価を行う必要があり、すべての特許関連法的責任を負うことになります。Dr. Reddy は、商品性、特定目的への適合性、および非侵害の保証を含むがこれらに限定されない、明示または黙示を問わずすべての保証を否認します。